Body

FINDINGS:

Cushing disease is a life-threatening disorder most commonly triggered by tumors, often benign, in the pituitary glands, resulting in excess production of adrenocorticotrophic hormone (ACTH). The condition is marked by progressive weight gain, excessive fatty tissue deposits and a rounding of facial features, known as "moon face," and can lead to diabetes, hypertension, osteoporosis, obesity and psychological disturbances.

Gastrointestinal bacteria are important for digestion, immune functions and general health. Wouter van Dongen and colleagues from the Konrad Lorenz Institute of Ethology of the Vetmeduni Vienna have collaborated with scientists from the Laboratoire Évolution & Diversité Biologique (EDB), Toulouse and from the US Geological Survey, Anchorage to study the cloacal bacterial assemblies of black-legged kittiwakes (Rissa tridactyla).

A protein called c-FLIP-R is critical to immune cell survival: If this molecule is missing, the cells kill themselves – and are thus no longer able to perform their job fighting off invaders. Now, scientists at the Helmholtz Centre for Infection Research (HZI) Braunschweig and at the Otto von Guericke University (OvGU) Magdeburg have published their findings in the European Journal of Immunology.

A new study by the Wildlife Conservation Society's Animal & Human Health for the Environment And Development (AHEAD) Program, World Wildlife Fund (WWF), and regional partners finds that a new approach to beef production in southern Africa could positively transform livelihoods for farmers and pastoralists, while helping to secure a future for wildlife and wildlife-based tourism opportunities.

CHICAGO, IL (May 29, 2013)—Researchers from Fox Chase Cancer Center will present data at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1, which shows the discovery of potential biomarkers that may be used to identify patients with head and neck cancer whose tumors are unlikely to respond to treatment by the targeted therapy cetuximab—a type of monoclonal antibody. The FDA approved the drug, in combination with radiation or as a second-line drug after chemotherapy had failed, in 2006.

CHICAGO, IL (May 29, 2013)—Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT). Preliminary findings will be presented by Shanthi Marur, first author on the study and an oncologist at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, at the 49th Annual Meeting of the American Society of Clinical Oncology on Sunday, June 2.

CHICAGO, IL (May 28, 2013)—A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's on the market, according research that scientists at Fox Chase Cancer Center will present at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1.

CHICAGO, IL (May 28, 2013)—Nearly two-thirds of solid tumors carry at least one mutation that may be targeted, or medicated, by an existing compound, according to new findings from researchers Fox Chase Cancer Center that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology on June 3. The results suggest that it may one day become commonplace for doctors to sequence tumors before deciding on a treatment regimen.

PHILADELPHIA — A newly developed, single-step Raman spectroscopy algorithm has the potential to simultaneously detect microcalcifications and enable diagnosis of the associated breast lesions with high precision, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

There is a lack of evidence regarding the effectiveness of technologies used to reduce arsenic contamination finds research in BioMed Central's open access journal Environmental Evidence. More studies assessing the technologies themselves and how they are used in the community are needed to ensure that people have access to safe, clean water.

Given the option, many women with symptoms of urinary tract infections are choosing to avoid antibiotics and give their bodies a chance to heal naturally, finds research in BioMed Central's open access journal BMC Family Practice. The research shows that 70% of women with symptoms of uncomplicated urinary tract infections who did not use antibiotics for a week were cured or showed improvement.

Probiotic supplements have the potential to prevent diarrhoea caused by antibiotics, according to a new Cochrane systematic review. The authors studied Clostridium difficile (C. difficile) infections in patients taking antibiotics and found symptoms of diarrhoea were substantially reduced when patients were also treated with probiotics.

Researchers have found that conditions in the womb can affect kidney development and have serious health implications for the child not only immediately after birth, but decades later.

In a paper published today in The Lancet an international team, including Monash University's Professor John Bertram and the University of Queensland's Professor Wendy Hoy, reviewed existing, peer-reviewed research on kidney health and developmental programming - the effects of the in utero environment on adult health.

Sharks are worth more in the ocean than in a bowl of soup, according to researchers from the University of British Columbia.

A new study, published today in Oryx – The International Journal of Conservation, shows that shark ecotourism currently generates more than US$314 million annually worldwide and is expected to more than double to US$780 million in the next 20 years.

Giving double doses of the antiviral drug oseltamivir, or Tamiflu, offers no clinical or virological advantages over a standard dose for patients admitted to hospital with severe influenza infection, according to a randomised trial published today and funded by the Wellcome Trust, US National Institute of Allergy and Infectious Diseases and the Singapore National Medical Research Council.